4
Total investments
0
Early stage
3
Mid stage
0
Late stage
2y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Mar 2025
The potential of biomanufacturing is clear — but scale has been the bottleneck. Curve exists to close that gap.
At Curve we combine expertise in engineering, biology and biochemistry to create robust, modular production systems for precision fermentation and cell cultivation. From food and health to chemicals and sustainable materials. Our technology bridges the gap between basic food-grade fermenters and costly pharma-grade bioreactors, with the goal to enable scale for resilient, efficient, and commercially viable biomanufacturing.
Angel Investor
Nov 2024
Fauna erstatter de fysiske dokumenter i kæledyrenes sundhedsbøger med en digital løsning, så kæledyrsejeren har et opdateret overblik over vaccinationer og andet relevant sundhedsdata lige ved hånden. Vi centraliserer information for kæledyrsejere, klinikker og andre interessenter i industrien, og er den nye app, der digitalt transformerer kæledyrsbranchen. Fauna er bygget ud fra altid at have kæledyret og deres ejer i centrum. Vi sikrer, at vores kæledyr har det godt og er sunde og raske ved at give kæledyrsejeren de bedste forudsætninger for at være en god ejer.
Angel Investor & IP Advisor
Jun 2024
IMP combines advanced digital sensor technology with AI-driven signal analysis to continuously track key early warning scores biomarkers from a single non-invasive wearable. Engineered for continuous 24/7 deployment in acute wards, emergency departments, and post-operative care - and equally suited to hospital-at-home and elder-care monitoring. IMP ships with its own low-energy, secure wireless transmission setup - no reliance on hospital Wi-Fi, no complex IT integration, and no infrastructure upgrades need. MDR 2017/745 (Class IIb) approved and ISO 13485 certified.
Experience · 7 entries
All (7)
Investments (4)
Founder (2)
Board (1)
2025
Angel Investor
Mar 2025
The potential of biomanufacturing is clear — but scale has been the bottleneck. Curve exists to close that gap.
At Curve we combine expertise in engineering, biology and biochemistry to create robust, modular production systems for precision fermentation and cell cultivation. From food and health to chemicals and sustainable materials. Our technology bridges the gap between basic food-grade fermenters and costly pharma-grade bioreactors, with the goal to enable scale for resilient, efficient, and commercially viable biomanufacturing.
Member of Innobooster panel
Jan 2025
Innovation Fund Denmark connects research, knowledge and ideas with the businesses and society that need them.
CEO & Co-Owner
Jan 2025
Welcome to Redox-Flow.com, where innovation meets simplicity. Founded in 2018 by a group of passionate Danish researchers specializing in redox chemistry, we have been on a mission to simplify your electrochemical research journey.
Our journey began with a vision to address key challenges in the field: decrease internal cell resistance, assembly speed, and user-friendliness. The result? Our very first creation – The A-Cell, Redox Flow Battery Test Cell. Since then, we have expanded our product range through collaboration with both academic and industrial partners who share our dedication.
At Redox-Flow.com, we believe in providing you with a shortcut to success. No need to reinvent the wheel; our products have undergone rigorous design iterations and extensive testing. We carefully select external products to offer you the best price-to-value ratio on the market. Our commitment is to recommend the best solutions tailored to your application.
When you reach out to us, we are not just interested in selling products; we are genuinely curious about your application. Your insights help us to understand how our products are used, enabling us to offer you more precise guidance.
In a nutshell, our philosophy is simple: we are here to make your life easier. Explore our products and let us simplify your electrochemical research journey together.
2024
Angel Investor
Nov 2024
Fauna erstatter de fysiske dokumenter i kæledyrenes sundhedsbøger med en digital løsning, så kæledyrsejeren har et opdateret overblik over vaccinationer og andet relevant sundhedsdata lige ved hånden. Vi centraliserer information for kæledyrsejere, klinikker og andre interessenter i industrien, og er den nye app, der digitalt transformerer kæledyrsbranchen. Fauna er bygget ud fra altid at have kæledyret og deres ejer i centrum. Vi sikrer, at vores kæledyr har det godt og er sunde og raske ved at give kæledyrsejeren de bedste forudsætninger for at være en god ejer.
Angel Investor & IP Advisor
Jun 2024
IMP combines advanced digital sensor technology with AI-driven signal analysis to continuously track key early warning scores biomarkers from a single non-invasive wearable. Engineered for continuous 24/7 deployment in acute wards, emergency departments, and post-operative care - and equally suited to hospital-at-home and elder-care monitoring. IMP ships with its own low-energy, secure wireless transmission setup - no reliance on hospital Wi-Fi, no complex IT integration, and no infrastructure upgrades need. MDR 2017/745 (Class IIb) approved and ISO 13485 certified.
Show all 7 entries ↓
Investment activity
2024–2025 · 4 investments
Recent (last 2 years)Earlier
